
Current Issue
March 2025
Banking on Artificial Blood
After years of investment, researchers are closer than ever to cashing in on a shelf-stable alternative.
Viewpoints
Editor’s Corner
Education
You Make the Call
You Make the Call Readers' Response
Hematologica Obscura
Often Misdiagnosed, Plasminogen Deficiency Has a Home in Hematology
Spotlight
Feature Articles
pASHions
Celebrating Irish Culture: Sarah O’Brien Dirk
News
In a Different Vein: News from the Blood Journals
Telemedicine Approach Helps Improve IC-Based SCD Pain Management
Azacitidine Plus Venetoclax May Offer a Path to HCT for Patients with High-Risk Treatment-Naïve Myelodysplastic Syndromes
Elderly Patients With BPDCN Respond Well to Venetoclax, Bortezomib, Dexamethasone Combination
Literature Scan
Obecabtagene Autoleucel Effective Treatment for Adults with B-ALL
Long-Term Survivors of Multiple Myeloma Have Persistent Immune Alterations
AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia
Study Confirms Safety, Efficacy of Mitapivat to Improve Anemia, Decrease Pain Crises in Sickle Cell Disease
PDUFA Pending
Fitusiran on the Horizon for Hemophilia
Approval Granted for New Acalabrutinib Indication
ASH Directions
Society Pages
Ohio State Names Director of Hematology
Data Stream
Online Exclusives
In a Different Vein: News from the Blood Journals
Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T
Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma
Literature Scan
Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry